Market Cap 47.18M
Revenue (ttm) 0.00
Net Income (ttm) -23.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,386,900
Avg Vol 646,062
Day's Range N/A - N/A
Shares Out 32.99M
Stochastic %K 77%
Beta 0.01
Analysts Sell
Price Target $14.00

Company Profile

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Industry: Biotechnology
Sector: Healthcare
Phone: 312-416-8592
Address:
444 West Lake Street, Suite 1700, Chicago, United States
rayankhader
rayankhader Oct. 27 at 6:01 PM
$MAIA adding somewhere
0 · Reply
DARKP00L
DARKP00L Oct. 27 at 3:23 PM
$MAIA 10:54 on Oct. 27 2025 MAIA Biotechnology Presents Trial In Progress Poster At 2025 AACR-NCI-EORTC Conference; Co. Enrolls Five Patients From Taiwan And Turkey In Expansion Phase Of THIO-101 Phase 2 Trial #tradeideas
0 · Reply
MoneyHelix
MoneyHelix Oct. 25 at 6:11 PM
$MAIA The data revealed in the Phase 3 poster is incredible. MAIA took scans of 19/70 patients after 9 months, and the tumors decreased in size by > 15% on average. This is a completely new data that wasn't revealed until this poster because Partial Responses in the swimmers plots only show up when the tumor shrinks by 30%. This activity is on patients that already failed CPI therapy, and this data is also across all dose levels, which means the 180mg dose could improve this data. This makes a 30% ORR in the pivotal Phase 2 trial even more likely, and thus Accelerate Approval in 3L NSCLC more likely. These patients have no other options, and THIO could come to market with tumor-shrinking activity, and 3x OS over standard of care. The swimmers plot was misleading because it showed a lot of "Stable Disease" data, but the underlying truth is that tumors were shrinkking in a lot of these patients.
3 · Reply
Rmart
Rmart Oct. 24 at 8:47 PM
$MAIA volume goes away and so do the comments
0 · Reply
conclusionsq
conclusionsq Oct. 24 at 3:04 AM
$MAIA large scale volume, but stock price is anchored. what is this mean?
0 · Reply
InfinityAndBeyond_
InfinityAndBeyond_ Oct. 24 at 2:37 AM
$BTQ $BYND $QNRX $MAIA AWX getting a lot of buzz, this low float is a former runner, if this catches volume expect a monster move tmr.
0 · Reply
_Sensei_
_Sensei_ Oct. 23 at 11:47 PM
$IMCC $MAIA $HKPD $SCNX Beautiful day today, nailed IMCC 1.85 to 3.35 for over 80% gains in the private discord. Also nailed MAIA 1.40 to 1.78 for 27% gain. Plenty of other winners to be had if you are watching my custom scanners closely. SCNX and INEO ran off my scanner, my scans also caught HKPD @ 1.21 around 9:50am today, HKPD ran to $1.81 so far. There is no shortage of winners when you have such a huge arsenal of tools.
0 · Reply
MoneyHelix
MoneyHelix Oct. 23 at 6:58 PM
$MAIA 15x average volume and climbing 30 months survival for a patient after reaching the treatment limit of 24 months More Phase 2 data revealed showing patient tumors shrinking over time on patients that failed 2 lines of therapy, including CPIs. Phase 3 poster revealed If MAIA can continue to raise money, they could be well into Phase 3 and get Accelerated Approval right as the Big Pharma Patent Cliffs start sinking revenues. That is the perfect storm for a bidding war. Regeneron, Roche, and BeOne already have MAIA on their radar. More players will be jumping in soon 📈🤑💰🤑📈
0 · Reply
vividC
vividC Oct. 23 at 6:57 PM
$MAIA good volume I suspect that MAIA raised some cash today.
0 · Reply
BetterDayzz
BetterDayzz Oct. 23 at 5:54 PM
$MAIA on watch 👀
0 · Reply
Latest News on MAIA
MAIA Biotechnology Announces $736,600 Private Placement

Oct 13, 2025, 4:20 PM EDT - 14 days ago

MAIA Biotechnology Announces $736,600 Private Placement


MAIA Biotechnology Announces $2.25 Million Private Placement

Sep 29, 2025, 4:30 PM EDT - 4 weeks ago

MAIA Biotechnology Announces $2.25 Million Private Placement


MAIA Biotechnology Announces $1.08 Million Private Placement

May 5, 2025, 4:05 PM EDT - 6 months ago

MAIA Biotechnology Announces $1.08 Million Private Placement


MAIA Biotechnology Announces Private Placement of $2,715,000

Feb 18, 2025, 3:44 PM EST - 8 months ago

MAIA Biotechnology Announces Private Placement of $2,715,000


MAIA Biotechnology to Present at Biotech Showcase 2025

Jan 10, 2025, 9:45 AM EST - 10 months ago

MAIA Biotechnology to Present at Biotech Showcase 2025


MAIA Biotechnology Announces $2.44 Million Private Placement

Oct 28, 2024, 7:00 PM EDT - 1 year ago

MAIA Biotechnology Announces $2.44 Million Private Placement


rayankhader
rayankhader Oct. 27 at 6:01 PM
$MAIA adding somewhere
0 · Reply
DARKP00L
DARKP00L Oct. 27 at 3:23 PM
$MAIA 10:54 on Oct. 27 2025 MAIA Biotechnology Presents Trial In Progress Poster At 2025 AACR-NCI-EORTC Conference; Co. Enrolls Five Patients From Taiwan And Turkey In Expansion Phase Of THIO-101 Phase 2 Trial #tradeideas
0 · Reply
MoneyHelix
MoneyHelix Oct. 25 at 6:11 PM
$MAIA The data revealed in the Phase 3 poster is incredible. MAIA took scans of 19/70 patients after 9 months, and the tumors decreased in size by > 15% on average. This is a completely new data that wasn't revealed until this poster because Partial Responses in the swimmers plots only show up when the tumor shrinks by 30%. This activity is on patients that already failed CPI therapy, and this data is also across all dose levels, which means the 180mg dose could improve this data. This makes a 30% ORR in the pivotal Phase 2 trial even more likely, and thus Accelerate Approval in 3L NSCLC more likely. These patients have no other options, and THIO could come to market with tumor-shrinking activity, and 3x OS over standard of care. The swimmers plot was misleading because it showed a lot of "Stable Disease" data, but the underlying truth is that tumors were shrinkking in a lot of these patients.
3 · Reply
Rmart
Rmart Oct. 24 at 8:47 PM
$MAIA volume goes away and so do the comments
0 · Reply
conclusionsq
conclusionsq Oct. 24 at 3:04 AM
$MAIA large scale volume, but stock price is anchored. what is this mean?
0 · Reply
InfinityAndBeyond_
InfinityAndBeyond_ Oct. 24 at 2:37 AM
$BTQ $BYND $QNRX $MAIA AWX getting a lot of buzz, this low float is a former runner, if this catches volume expect a monster move tmr.
0 · Reply
_Sensei_
_Sensei_ Oct. 23 at 11:47 PM
$IMCC $MAIA $HKPD $SCNX Beautiful day today, nailed IMCC 1.85 to 3.35 for over 80% gains in the private discord. Also nailed MAIA 1.40 to 1.78 for 27% gain. Plenty of other winners to be had if you are watching my custom scanners closely. SCNX and INEO ran off my scanner, my scans also caught HKPD @ 1.21 around 9:50am today, HKPD ran to $1.81 so far. There is no shortage of winners when you have such a huge arsenal of tools.
0 · Reply
MoneyHelix
MoneyHelix Oct. 23 at 6:58 PM
$MAIA 15x average volume and climbing 30 months survival for a patient after reaching the treatment limit of 24 months More Phase 2 data revealed showing patient tumors shrinking over time on patients that failed 2 lines of therapy, including CPIs. Phase 3 poster revealed If MAIA can continue to raise money, they could be well into Phase 3 and get Accelerated Approval right as the Big Pharma Patent Cliffs start sinking revenues. That is the perfect storm for a bidding war. Regeneron, Roche, and BeOne already have MAIA on their radar. More players will be jumping in soon 📈🤑💰🤑📈
0 · Reply
vividC
vividC Oct. 23 at 6:57 PM
$MAIA good volume I suspect that MAIA raised some cash today.
0 · Reply
BetterDayzz
BetterDayzz Oct. 23 at 5:54 PM
$MAIA on watch 👀
0 · Reply
HarrySmith747
HarrySmith747 Oct. 23 at 5:53 PM
$MAIA pioneering biotech, AITX pioneering AI automation — global partnerships like Propertysec set the pace for scale.
0 · Reply
conclusionsq
conclusionsq Oct. 23 at 5:01 PM
$MAIA what is going on… go up plz
0 · Reply
DiamondDog33
DiamondDog33 Oct. 23 at 3:04 PM
$MAIA FUNNY!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! ANOTHER HYPED UP RELEASE .....without number of Patients COMPANY HAS NO MONEY ......and unable to do A LARGE SCALE TRIAL!!!!! Might get to market by 2030-2031 .. V hitting a timeline like me going to the moon THE WARRANT KINGS! sub 1
2 · Reply
MAIA_Biotechnology
MAIA_Biotechnology Oct. 23 at 2:38 PM
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer. Read the press release: https://ir.maiabiotech.com/news-events/press-releases/detail/155/maia-biotechnology-details-30-month-patient-survival-in $MAIA
0 · Reply
BioTuesdays
BioTuesdays Oct. 23 at 2:03 PM
$MAIA has announced highlights from a presentation at the European Society for Medical Oncology (ESMO) Congress 2025 held in Berlin, Germany, showcasing its ongoing Phase 2 and Phase 3 trials of ateganosine in non-small cell lung cancer (NSCLC) https://biotuesdays.com/2025/10/23/maia-details-exceptional-survival-in-third-line-nsclc-at-esmo/
0 · Reply
MHM7700
MHM7700 Oct. 23 at 12:58 PM
42% win on traded capital in less than 30 minutes on $ENTX, $MAIA and $INBS. That means if you invested 1,000 this morning, you would be walking off with more than 400 now as these trades were apart in time and you could use the same capital again and again. This is what we do everyday in our discord. This is what you get when you trade with real traders instead of FURUs here who just talk. I give clear trade alerts with PTs and SLs every time along with proof of me taking the same trade.
2 · Reply
DaBullRunner
DaBullRunner Oct. 23 at 12:48 PM
$SCNX profit will go going to INEO off that news This should be back over $1 and more later 🎯✅ $MAIA $SILO $AIRE $IBIO let’s make big money bulls
0 · Reply
patb99
patb99 Oct. 23 at 12:47 PM
$MAIA 😱
0 · Reply
MHM7700
MHM7700 Oct. 23 at 12:47 PM
5% win on the $MAIA trade. scaled out 50% each time @ 1.75 from 1.66 long entry. https://stocktwits.com/MHM7700/message/633398227
0 · Reply
GSP
GSP Oct. 23 at 12:46 PM
Latest gapper list for Thursday (con't): $IBIO $TNGX $SCNX $BIOA $MAIA .
0 · Reply
deepeeenn
deepeeenn Oct. 23 at 12:45 PM
$MAIA tall need to look back to last week when they announced private placement valued at $1.22/share
0 · Reply